Qsemble Capital Management, LP Gilead Sciences, Inc. Transaction History

Qsemble Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$63.15 - $72.88 $98,198 - $113,328	-1,555 Reduced 3.85%	38,841 $2.66 Billion
Q1 2024 May 07, 2024	BUY	$71.58 - $87.29 $2.89 Million - $3.53 Million	40,396 New	40,396 $2.96 Billion
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $610,749 - $695,832	7,900 Added 158.0%	12,900 $1.07 Billion
Q4 2022 Feb 09, 2023	BUY	$62.32 - $89.47 $311,600 - $447,350	5,000 New	5,000 $429 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Qsemble Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Qsemble Capital Management, LP with notifications on news.